Safety End Points

(P-006) Stroke Risk Associated with Incident Antidepressant Use: Delineated with Age

(P-009) Proton Pump Inhibitors and Risk of End Stage Renal Disease in Patients with Chronic Kidney Disease

(P-017) Comparison of the Incidence of Bleeding Between Anti-influenza Drugs Among Outpatients for the Influenza Virus Infection: A Retrospective Study Using an Employment-based Health Insurance Claims Database in Japan

(P-050) Cohort Study Assessing Angioedema Risk in Black Heart Failure Patients Using Angiotensin-converting Enzyme Inhibitors in the United States– Interim Results

(P-059) Diagnostic Delay, Effectiveness and Safety Outcomes in a Real-world Cohort of Patients with Crohn’s Disease: Data from Administrative Databases in Tuscany, Italy

(P-065) Safety of Rivaroxaban in First-time Users Treated for Deep Vein Thrombosis and Pulmonary Embolism

(P-098) Risk of Intracranial Meningioma Requiring Surgical Intervention Among Recent Hormonal Contraceptives Users

(P-125) Risk of Thyroid Cancer with the Use of GLP-1 Receptor Agonists

(P-126) The Use of Lag Times in Cancer Pharmacoepidemiology

(P-146) Safety of Ovaleap® (Follitropin Alfa) in Infertile Women Undergoing Superovulation for Assisted Reproductive Technologies (SOFIA): A Multinational Comparative, Prospective Cohort Study

(P-169) The Association Between Proton Pump Inhibitors and Increased Risk of Hyponatremia - A Cohort Study

(P-212) Determinants of Intravenous Admixture Preparation Errors: A Prospective Observational Study

(P-229) Adverse Events in NSCLC Patients Treated with Docetaxel Monotherapy

(P-242) Nsaids and Risk of Myocardial Infarction in Patients with No Major Risk Factors: A Nested Case-control Study in the UK Clinical Practice Research Datalink

(P-252) Safety and Effectiveness of Rivaroxaban in First-time Users with Non-valvular Atrial Fibrillation in Routine Practice

(P-271) Association Between the Multiple Myeloma Treatments and Vascular Adverse Events in Taiwanese Multiple Myeloma Patients: A Population-based Cohort Study

(P-354) A Retrospective Database Study to Evaluate Incidence of Influenza and Influenza-like Illness (ILI) Among Rheumatoid Arthritis (RA) Patients Taking Conventional Synthetic Disease Modifying Antirheumatic Drugs (csDMARD)

(P-420) The Prevalence and Associated Risk Factors of Perfumes Sensitivity in Saudi Arabia

(P-428) Incidence of Angioedema After Initiation of Angiotensin-converting Enzyme Inhibitors in Adults with Heart Failure

(P-466) Risk of Emergency Department Visits or Hospitalization for Cardiovascular Events in Patients with Medical Cannabis Authorization

(P-498) Sulfonylureas and the Risk of Ventricular Arrhythmias Among Patients with Type 2 Diabetes: A Systematic Review of Observational Studies

(P-524) Conduction Disorders/dysrhythmias and Hydroxychloroquine in Rheumatoid Arthritis

(P-535) Retinal Toxicity in a Multinational Inception Cohort of Systemic Lupus Patients on Hydroxychloroquine

(P-636) Risk of Acute Respiratory Failure Among Non-elderly Patients with Solid Tumors Receiving Pegfilgrastim and Concomitant Opioids: A Nested Case-control Study